Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Takes a Stake in Microgenomics Firm Arcturus

NEW YORK, Dec. 9-Affymetrix has partnered with laser capture microdissection company Arcturus, the company said today.


Through the partnership, Arcturus will be able to use Affymetrix' chips and gene expression tools in order to develop new array-based diagnostic products.


Affymetrix invested $3 million in Arcturus as part of a recent round of financing.


Arcturus, based in Mountain View, Calif., develops instruments for "microgenomics"-analyzing nucleic acids and proteins from laser captured cells. The company is also working to develop this technique for new diagnostics.


For more information, see the company website.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.